Program Learning Objectives
The Program Learning Objectives for the masters program in Clinical and Experimental Therapeutics are available here.
A minimum of 24 core-curriculum courses (see Course Offerings below) with an additional four units from research and dissertation courses are required for graduation, including CXPT 594A and 594B (MS thesis). The core curriculum emphasizes preclinical experimental therapeutic drug development (CXPT 609) and Clinical problem solving (CXPT 664). Additionally principles of biostatistics or equivalent (e.g. PM 510-L) are required for graduation.
Research can be initiated at any point in the program. Students selecting the non-research master’s track may elect and are encouraged to carry out research in their program.
All students are expected to conduct research leading to a MS thesis or, at minimum, a scholarly project. Whereas a thesis is original research, a scholarly project can be a comprehensive review of the literature. The scope of the thesis or scholarly project is determined between the student and their advisor. The submitted thesis or scholarly project should comprehensively cover background and specific aims as to why the research was undertaken. Additionally, a description of the methods/procedures, analysis and conclusion are critical components of the thesis or scholarly project.
Graduate students are expected to possess knowledge in various areas of pharmaceutical and translational sciences. The following are graduate courses offered by the program (some courses are not offered every year):
USC Course Catalogue
For Clinical and Experimental Therapeutics (CXPT) courses, see School of Pharmacy: USC Course Catalogue
Schedule of Classes
For course availability for the current year see the Schedule of Classes.